Nanoerythrosomes, a new derivative of erythrocyte ghost: IV. Fate of reinjected nanoerythrosomes

Anticancer Research

Volumn 21, Issue 3 B, 2001, Pages 1741-1747

  Desilets J ^a   Lejeune, A ^a   Mercer, J ^a   Gicquaud, C ^a  

^a UNIVERSITÉ DU QUÉBEC À TROIS RIVIÈRES   (Canada)

Author keywords

Biodistribution; Drug delivery system; Erythrosome derivatives; Nanoerythrosomes; Red blood derivatives

Indexed keywords

ANTINEOPLASTIC AGENT; DAUNORUBICIN; DRUG CARRIER; NANOPARTICLE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CENTRIFUGATION; CONTROLLED STUDY; DIALYSIS; ERYTHROCYTE GHOST; INGUINAL LYMPH NODE; LIVER; MALE; MEMBRANE VESICLE; MICROSCOPY; MOUSE; NONHUMAN; PARTICLE SIZE; PLASMA CLEARANCE; PRIORITY JOURNAL; PURIFICATION; SPLEEN; TISSUE DISTRIBUTION;

ANIMALS; DRUG CARRIERS; ERYTHROCYTE MEMBRANE; IODINE RADIOISOTOPES; LIVER; LUNG; LYMPH NODES; MALE; MICE; MICROSCOPY, ELECTRON; SPLEEN; TISSUE DISTRIBUTION;

EID: 0034910981     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Hypotonically loaded rat erythrocytes deliver encapsulated substances into peritoneal macrophages
2. Phagocytosis of enzyme-containing carrier erythrocytes by macrophages
3. Erythrocytes as carriers for recombinant cloned DNA
4. Erythrocyte membrane bound daunorubicin as a delivery system in anticancer treatment
5. Encapsulation of doxorubicin in liver-targeted erythrocytes increases the therapeutic index of the drug in a murine metastatic model
6. Optimized recirculation survival of mouse carrier erythrocytes
7. Carrier erythrocytes: Clinical pharmacokinetic consideration
8. Improved pharmacodynamics of L-asparaginase-loaded in human red blood cells
9. Nanoerythrosomes, a new derivative of erythrocyte ghost: Preparation and antineoplastic potential as drug carrier for daunorubicin
10. Nanoerythrosomes, a new derivative of erythrocyte ghost II: Identification of the mechanism of action
11. Surface-specific iodination of membrane proteins of viruses and eucaryotic cells using 1, 3, 4, 6-tetrachloro-3a, 6a-diphenylglycouril (IODO-GEN®)
12. Resealing of protein tyrosine kinase substrates into human erythrocytes by rapid freezing and thawing in liquid nitrogen
13. Localization of colloidal particles (liposomes, hexyl-cyanoacrylate nanoparticles and albumin nanoparticles) by histology and autoradiography in mice
14. In situ hybridization of immunoglobulin specific RNA in single cells of the lympho lineage with radiolabelled DNA probes
15. Intrahepatic uptake and processing of intravenously injected small unilamellar liposomes in rats
16. Intrahepatic distribution of small unilamellar liposomes as a function of liposomal lipid composition
17. Uptake of liposomes by rat and mouse hepatocytes and Kupfer cells
18. Intrahepatic distribution of long-circulating liposomes containing poly (ethylene glycol) distearoyl phosphatidylethanolamine
19. The prolongation of the survival times of mice implanted with TLX5 cells by treatment with methotrexate encapsulated in erythrocytes
20. Survival of murine carrier erythrocytes injected via the peritoneum
21. Senescence of red blood cells: Progress and problems
22. Definition of a physiologic aging autoantigen by using synthetic peptides of membrane proteins 3: Localization of the active antigenic sites
23. Clustering of integral membrane proteins of the human erythrocyte membrane stimulates autologous IgG binding, complement deposition, and phagocytosis
24. Oxidation as a possible mechanism of cellular aging: Vitamin E deficiency causes premature aging and IgG binding to erythrocytes
25. Human natura anti-alpha-galactosyl IgG. II. The specific recognition of alpha (1-3)-linked galactose residues
26. Recognition of red blood cells by macrophages: Role of phosphatidylserine and possible implications of membrane phospholipid asymmetry
27. Phosphatidylserine vesicles inhibit phagocytosis of erythrocytes with a symmetric transbilayer distribution of phospholipids
28. Antioxidant systems and erythrocyte life-span in mammals
29. Iron release, membrane protein oxidation and erythrocyte ageing
30. Poly-N-acetyllactosaminyl saccharide chains of band 3 as determinants for anti-band 3 auto-antibody binding to senescent and oxidized erythrocytes
31. Subcutaneous administration of liposomes: A comparison with the intravenous and intraperitoneal routes of injection
32. Effects of administered route on tissue distribution and antitumor activity of polyethyleneglycol-coated liposomes containing adriamycin
33. Nanoerythrosomes, a new derivative of erythrocyte ghost: III Is phagocytosis involved in the mechanism of action?